RITUXIMAB FOR INDUCTION OF REMISSION IN TYPE 1 AUTOIMMUNE PANCREATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引:0
|
作者
Lanzillotta, M. [1 ]
Capurso, G. [2 ]
Wallace, Z. [3 ]
Karadag, O. [4 ]
Dagna, L.
Della Torre, E.
机构
[1] Ist Sci San Raffaele, Unit Immunol Rheumatol Allergy & Rare Dis, Milan, Italy
[2] Ist Sci San Raffaele, PancreatoBiliary Endoscopy & EUS Div, Milan, Italy
[3] Massachusetts Gen Hosp, Clin Epidemiol Unit, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA
[4] Hacettepe Univ, Fac Med, Dept Internal Med, Div Rheumatol, Ankara, Turkey
关键词
D O I
10.1136/annrheumdis-2021-eular.3993
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS1382
引用
收藏
页码:974 / 974
页数:1
相关论文
共 50 条
  • [1] Determination of the duration of glucocorticoid therapy in type 1 autoimmune pancreatitis: A systematic review and meta-analysis
    Yoon, Seung Bae
    Moon, Sung-Hoon
    Kim, Jong Hyeok
    Park, Ji Won
    Kim, Sung Eun
    Kim, Myung-Hwan
    [J]. PANCREATOLOGY, 2021, 21 (06) : 1199 - 1207
  • [2] Correlation of Autoimmune Pancreatitis and Malignancy: Systematic Review and Meta-Analysis
    Hossein Haghbin
    Justin Chuang
    Rawish Fatima
    Nuruddinkhodja Zakirkhodjaev
    Wade Lee-Smith
    Muhammad Aziz
    [J]. Digestive Diseases and Sciences, 2022, 67 : 3252 - 3264
  • [3] Correlation of Autoimmune Pancreatitis and Malignancy: Systematic Review and Meta-Analysis
    Haghbin, Hossein
    Chuang, Justin
    Fatima, Rawish
    Zakirkhodjaev, Nuruddinkhodja
    Lee-Smith, Wade
    Aziz, Muhammad
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (07) : 3252 - 3264
  • [4] SAFETY OF RITUXIMAB THERAPY IN AUTOIMMUNE DISEASES: SYSTEMATIC REVIEW AND META-ANALYSIS
    Kobayashi, K.
    Minegishi, K. M.
    Horita, N.
    Ohno, S.
    Nakajima, H. N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1191 - 1191
  • [5] Methotrexate as Induction of Remission Therapy for Type 1 Autoimmune Pancreatitis
    Rovati, Lucrezia
    Lanzillotta, Marco
    Bozzolo, Enrica
    Arcidiacono, Paolo Giorgio
    Falconi, Massimo
    Dagna, Lorenzo
    Della-Torre, Emanuel
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (05): : 831 - 833
  • [6] Tofacitinib for induction of remission in ulcerative colitis: systematic review and meta-analysis
    Paschos, P.
    Katsoula, A.
    Giouleme, O.
    Tsapas, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S418 - S419
  • [7] Tofacitinib for induction of remission in ulcerative colitis: systematic review and meta-analysis
    Paschos, Paschalis
    Katsoula, Anastasia
    Giouleme, Olga
    Sarigianni, Maria
    Liakos, Aris
    Athanasiadou, Eleni
    Bekiari, Eleni
    Tsapas, Apostolos
    [J]. ANNALS OF GASTROENTEROLOGY, 2018, 31 (05): : 572 - 582
  • [8] RITUXIMAB FOR INDUCTION OF REMISSION IN IGG4-RELATED PANCREATO-BILIARY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Lanzillotta, M.
    Della Torre, E.
    Falconi, M.
    Arcidiacono, P. G.
    Dagna, L.
    Capurso, G.
    [J]. DIGESTIVE AND LIVER DISEASE, 2021, 53 : S183 - S184
  • [9] Efficacy and safety of rituximab in autoimmune pancreatitis type 1: our experiences and systematic review of the literature
    Nikolic, Sara
    Panic, Nikola
    Hintikka, Elina Sofia
    Dani, Lara
    Rutkowski, Wiktor
    Hedstrom, Aleksandra
    Steiner, Corinna
    Lohr, J. -Matthias
    Vujasinovic, Miroslav
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021, 56 (11) : 1355 - 1362
  • [10] Traditional corticosteroids for induction of remission in Crohn disease: a systematic review and meta-analysis
    Benchimol, E.
    Seow, C.
    Steinhart, A.
    Griffiths, A.
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (01) : S11 - S11